Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling (original) (raw)

References

• Abreu-Martin MT, Chari A, Palladino AA, Craft NA, Sawyers CL . 1999 Mol. Cell Biol. 19: 5143–5154
• Amler LC, Agus DB, LeDuc C, Sapinoso ML, Fox WD, Kern S, Lee D, Wang V, Leysens M, Higgins B, Martin J, Gerald W, Dracopoli N, Cordon-Cardo C, Scher HI, Hampton GM . 2000 Cancer Res. 60: 6134–6141
• Brunn GJ, Williams J, Sabers C, Wiederrecht G, Lawrence Jr JC, Abraham RT . 1996 EMBO J. 15: 5256–5267
• Bubendorf L, Kolmer M, Kononen J, Koivisto P, Mousses S, Chen Y, Mahlamaki E, Schraml P, Moch H, Willi N, Elkahloun AG, Pretlow TG, Gasser TC, Mihatsch MJ, Sauter G, Kallioniemi OP . 1999 J. Natl. Cancer Inst. 91: 1758–1764
• Cheng L, Sun J, Pretlow TG, Culp J, Yang NS . 1996 J. Natl. Cancer Inst. 88: 607–611
• Craft N, Sawyers CL . 1998 Cancer Metastasis Rev. 17: 421–427
• Craft N, Shostak Y, Carey M, Sawyers CL . 1999 Nat. Med. 5: 280–285
• Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H . 1994 Cancer Res. 54: 5474–5478
• Dilling MB, Dias P, Shapiro DN, Germain GS, Johnson RK, Houghton PJ . 1994 Cancer Res. 54: 903–907
• Gregory CW, Hamil KG, Kim D, Hall SH, Pretlow TG, Mohler JL, French FS . 1998 Cancer Res. 58: 5718–5724
• Hosoi H, Dilling MB, Liu LN, Danks MK, Shikata T, Sekulic A, Abraham RT, Lawrence Jr JC, Houghton PJ . 1998 Mol. Pharmacol. 54: 815–824
• Khan J, Simon R, Bittner M, Chen Y, Leighton SB, Pohida T, Smith PD, Jiang Y, Gooden GC, Trent JM, Meltzer PS . 1998 Cancer Res. 58: 5009–5013
• Kunz J, Henriquez R, Schneider U, Deuter-Reinhard M, Movva NR, Hall MN . 1993 Cell 73: 585–596
• Liu J, Farmer Jr JD, Lane WS, Friedman J, Weissman I, Schreiber SL . 1991 Cell 66: 807–815
• Mousses S, Bittner ML, Chen Y, Doughtery ER, Baxevanis A, Meltzer PS, Trent JM . 2000 Functional Genomics: Gene Expression Analysis by cDNA Microarrays Livesey FJ and Hunt SP (eds) Oxford University Press: Oxford pp 113–137
  Google Scholar
• Nagabhushan M, Miller CM, Pretlow TP, Giaconia JM, Edgehouse NL, Schwartz S, Kung HJ, de Vere White RW, Gumerlock PH, Resnick MI, Amini SB, Pretlow TG . 1996 Cancer Res. 56: 3042–3046
• Nair SC, Rimerman RA, Toran EJ, Chen S, Prapapanich V, Butts RN, Smith DF . 1997 Mol. Cell.Biol. 17: 594–603
• Peterziel H, Mink S, Schonert A, Becker M, Klocker H, Cato AC . 1999 Oncogene 18: 6322–6329
• Pretlow TG, Wolman SR, Micale MA, Pelley RJ, Kursh ED, Resnick MI, Bodner DR, Jacobberger JW, Delmoro CM, Giaconia JM, et al. 1993 J. Natl. Cancer Inst. 85: 394–398
• Sabers CJ, Martin MM, Brunn GJ, Williams JM, Dumont FJ, Wiederrecht G, Abraham RT . 1995 J. Biol. Chem. 270: 815–822
• Sekulic A, Hudson CC, Homme JL, Yin P, Otterness DM, Karnitz LM, Abraham RT . 2000 Cancer Res. 60: 3504–3513
• Wainstein MA, He F, Robinson D, Kung HJ, Schwartz S, Giaconia JM, Edgehouse NL, Pretlow TP, Bodner DR, Kursh ED, Pretlow TG . 1994 Cancer Res. 54: 6049–6052

Download references